ABCC1 and glioblastoma: Interestingly, inhibition of cyclic nucleotide-specific phosphodiesterases, which are frequently upregulated in GBM and thus considered a promising avenue for GBM therapy, was significantly potentiated by MRP1 inhibition, thereby providing a new combination therapy for this malignancy [135].